All these medications, like nebivolol, can affect blood pressure and/or heart function.
Insucor with food and drinks
See section 3.
Pregnancy and breastfeeding
Pregnancy
Insucor should not be administered during pregnancy unless clearly necessary.
Breastfeeding
Its use is not recommended during breastfeeding.
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
This medication may cause dizziness or fatigue. If this occurs,do notdrive or operate machinery.
Insucor contains lactose
This medication containslactose. Ifyour doctor has told you that you have a certain sugar intolerance,consultbefore taking this medication.
Insucor contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per coated tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Insucor can be taken before, during, or after meals, but it can also be taken independently of them. It is preferable to take the tablet with a little water.
Treatment of high blood pressure (hypertension)
Treatment of chronic heart failure
Your doctor will closely monitor your treatment.
Your doctor may decide that it is necessary to combine these tablets with other medications to treat your condition.
If your doctor has instructed you to take ½ (half) tablet daily, consult the instructions below on how to break Insucor 2.5 mg and Insucor 5 mg tablets into equal doses.
• Place the tablets on a flat, hard surface (e.g., a table or countertop), with the score line facing upwards.
• Break the tablet by pushing it with your index fingers from both hands along the score line (Diagrams 1 and 2).
Diagram 1Diagram 2
Diagrams 1 and 2: easy breaking of Insucor 2.5 mg and Insucor 5 mg tablets into equal doses.
Use in children and adolescents
Do not use in children and adolescents.
If you take more Insucor than you should
If you have accidentally taken an overdose of this medication, consult your doctor or pharmacist immediately or call the Toxicological Information Service, telephone 91 562 04 20, indicating the medication and the amount taken. The symptoms and signs most frequently reported with an overdose are related to a very slow heart rate (bradycardia), low blood pressure with possible fainting (hypotension), difficulty breathing such as in asthma (bronchospasm), and acute heart failure.
You can take activated charcoal (available at your pharmacy) while waiting for help to arrive.
If you forget to take Insucor
If you forget to take a dose of Insucor, but remember shortly after when you should have taken it, take the dose as usual. On the other hand, if a lot of time has passed (several hours), so that it is near the next dose, skip the missed dose and take the next scheduled dose at the usual time. Do not take a double dose. However, you should try to avoid repeated forgetfulness of medication intake.
If you interrupt treatment with Insucor
Always consult your doctor before interrupting treatment with Insucor, whether you are taking it for high blood pressure or chronic heart failure.
You must not stop treatment abruptly. Always consult your doctor before interrupting treatment with Insucor, whether you are taking it for high blood pressure or chronic heart failure.
If it is necessary to interrupt treatment for chronic heart failure, the daily dose should be gradually reduced, halving the dose at weekly intervals. If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking nebivolol and talk to your doctor immediately if you have any of the following side effects:
When Nebivolol is used for the treatment of high blood pressure, its possible side effects are:
Frequent side effects (may affect up to 1 in 10 people):
Rare side effects (may affect up to 1 in 100 people):
Very rare side effects (may affect up to 1 in 10,000 people):
The following side effects have been reported only in isolated cases during treatment with this medicine:
In a clinical study forchronic heart failure, the following side effects were observed:
Frequent side effects (may affect more than 1 in 10 people):
Frequent side effects (may affect up to 1 in 10 people):
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly to the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the blister pack after CAD.
The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.If the medication loses its color or shows any signs of deterioration, ask your pharmacist for advice, who will tell you what to do.
Composition of Insucor
The active ingredient is nebivolol.
Each tablet contains 5 mg of nebivolol, equivalent to 5.45 mg of nebivolol hydrochloride.
The other components are:
Lactose monohydrate, cornstarch, sodium croscarmellose, hypromellose, microcrystalline cellulose, anhydrous colloidal silica, and magnesium stearate.
Appearance of the product and contents of the package
Biconvex, non-coated, circular tablets with a white color, with the legend “N” and “L” engraved on opposite sides of a groove on one side, and smooth on the other. The tablets can be divided into equal doses.
Insucor 5 mg tablets are presented in blisters containing 14, 28, 30, 50, 90, 98, 100 tablets.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Glenmark Arzneimittel GmbH
Industriestr. 31
82194 Gröbenzell
Germany
Responsible manufacturer:
Glenmark Pharmaceuticals s.r.o.
Fibichova 143
56617 Vysoke Myto
Czech Republic
Glenmark Generics (Europe) Ltd.
The Old Sawmill, Hatfield Park
Hatfield, Herts., AL9 5PG
United Kingdom
For more information about this medication, please contact the local representative of the marketing authorization holder:
Viso Farmacéutica, S.L.U.
c/ Retama 7, 7ª Planta
28045 Madrid
Spain
This medication is authorized in the member states of the European Economic Area with the following names:
GermanyNebivolol Glenmark 5 mg Tabletten
HungaryNebitrix 5 mg
NetherlandsNebivolol Glenmark 5 mg tabletten
SlovakiaNebitrix 5 mg
SpainINSUCOR 5 mg tablets
Last review date of this leaflet: April 2025
More detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS):http://www.aemps.gob.es//
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.